Hepatitis C Virus NS5A Protein–A Master Regulator?

Slides:



Advertisements
Similar presentations
 Hepatitis C virus (HCV) infects 170 million people worldwide  up to 80% of those infected become chronic infection.  HCV infection can cause chronic.
Advertisements

HCV Protease Yasir Waheed. Discovery of Hepatitis C.
Flaviviridae Positive stranded RNA viruses. Flaviviridae Enveloped virions made up of a lipid bilayer with two or more types of envelope (E) glycoproteins.
Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
Jean Dubuisson, François-Loïc Cosset  Journal of Hepatology 
Chapter 7. 주조직적합성 복합체 1. 주조직적합성 복합체 (MHC)의 발견 2. MHC 분자의 구조
Jean-Michel Pawlotsky  Gastroenterology 
John W. Bloom, MD  Journal of Allergy and Clinical Immunology 
Structural biology of hepatitis C virus
The benefits of integration
Hepatitis C Virus NS5A Protein–A Master Regulator?
Occult Hepatitis C Virus Infection: Are We Digging Too Deep?
Sustaining Proliferative Signaling and Evading Growth Suppressors
Hepatitis C virus infection
Vineela Chukkapalli, Glenn Randall  Gastroenterology 
Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
Cell Biology I. Overview
HCV NS5A Inhibitors: The Devil Is in the Details
Reciprocal Effects of Micro-RNA-122 on Expression of Heme Oxygenase-1 and Hepatitis C Virus Genes in Human Hepatocytes  Ying Shan, Jianyu Zheng, Richard.
Volume 142, Issue 6, Pages (May 2012)
Volume 138, Issue 3, Pages e2 (March 2010)
Figure 1 HCV life cycle and site of action of DAAs
Mechanisms of HBV-related hepatocarcinogenesis
Jing Zhang, Thomas M. Roberts, Ramesh A. Shivdasani  Gastroenterology 
Volume 61, Issue 2, Pages (August 2014)
Volume 148, Issue 7, Pages (June 2015)
Hepatitis B “X” gene linked to cellular calcium release
Emerging Therapeutic Targets for Hepatitis C Virus Infection
Cell Biology I. Overview
David Paul, Vanesa Madan, Ralf Bartenschlager  Cell Host & Microbe 
Comprehensive analysis of mutations in the hepatitis delta virus genome based on full- length sequencing in a nationwide cohort study and evolutionary.
Jean–Michel Pawlotsky, Stéphane Chevaliez, John G. McHutchison 
Disaccharide Digestion: Clinical and Molecular Aspects
Hepatitis C virus–cell interactions and their role in pathogenesis
Prion-like Domains Program Ewing’s Sarcoma
Timothy M. Block, Ju-Tao Guo  Gastroenterology 
Volume 119, Issue 6, Pages (December 2000)
Volume 131, Issue 6, Pages (December 2006)
Hepatitis C and Evasion of the Interferon System: A PKR Paradigm
Volume 117, Issue 5, Pages (November 1999)
The Neurobiology of Zika Virus
Pathogenesis of Flavivirus Infections: Using and Abusing the Host Cell
Long Noncoding RNA in Hematopoiesis and Immunity
Interferon-Free Treatment Regimens for Hepatitis C: Are We There Yet?
Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
New therapies on the horizon for hepatitis C
Interleukin-28b: A Key Piece of the Hepatitis C Virus Recovery Puzzle
Smad proteins and transforming growth factor-β signaling
Rik van der Kant, Lawrence S.B. Goldstein  Developmental Cell 
Volume 132, Issue 1, Pages 5-6 (January 2007)
Prevalence and Treatment of Hepatitis C Virus Genotypes 4, 5, and 6
Lost in Translation: An Antiviral Plant Defense Mechanism Revealed
Antigen-Receptor Signaling to Nuclear Factor κB
Jean Dubuisson, François-Loïc Cosset  Journal of Hepatology 
Immune Signaling by RIG-I-like Receptors
Anti−Hepatitis C Virus Drugs in Development
Volume 5, Issue 3, Pages (March 1997)
Simplified overview of the HCV life cycle and sites of direct acting antiviral therapies. Simplified overview of the HCV life cycle and sites of direct.
30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology
Volume 21, Issue 7, Pages (July 2014)
Jun-Young Seo, Rakina Yaneva, Peter Cresswell  Cell Host & Microbe 
Jean-Michel Pawlotsky  Gastroenterology 
Relationship between Genotype and Phenotype
Comprehensive analysis of mutations in the hepatitis delta virus genome based on full- length sequencing in a nationwide cohort study and evolutionary.
Philippe Metz, Antje Reuter, Silke Bender, Ralf Bartenschlager 
Guilty as charged Cancer Cell
Volume 7, Issue 1, Pages 1-11 (July 1997)
Understanding How Hepatitis C Virus Builds Its Unctuous Home
Brief Review – Growth Factors and Receptors
Update on glucocorticoid action and resistance
Presentation transcript:

Hepatitis C Virus NS5A Protein–A Master Regulator? Gyongyi Szabo  Gastroenterology  Volume 130, Issue 3, Pages 995-999 (March 2006) DOI: 10.1053/j.gastro.2006.01.072 Copyright © 2006 American Gastroenterological Association Terms and Conditions

Figure 1 The schematic diagram of the hepatitis C virus genome and non-structural (NS) 5A protein. The Hepatitis C virus has a plus-strand, 9.6 kb RNA genome that carries a single long open reading frame (ORF) with 5′ and 3′ flanked ends required for RNA translation and replication. The viral genes are expressed as a polyprotein, 3,000 amino acids in length, which is cleaved co- and post-translationally by host cell signal peptidases and two viral proteinases. At least 10 different cleavage products have been identified, which are ordered within the polyprotein: NH2-core-E1-E2-p7-NS2-NS3-NS4A-NS4B-NS5A-NS5B-COOH. The NS5A protein has a variety of functions, including participation in polyprotein clevage and interaction with host proteins and thus modulation of host homeostasis. NS5A has 447 aa and is divided into 2 low complexity sequences. The domain organization model for HCV NS5A includes domain I (amino acids 1–213), domain II (amino acids 250–342), and domain III (amino acids 355–447). The N-terminal 30 aa forms a highly conserved amphipathic α-helix necessary for association of NS5A with the endoplasmic reticulum membrane (membrane anchor). The NS5A protein is highly phosphorylated and residues 2200–2250 and 2350–2419, also called hyperphosphorylation cluster, are required for basal phosphorylation. The NS5A protein also contains: (1) An unconventional, cysteine-rich zinc binding motif within the N-terminal domain (Zn binding site, aa 36–100) that is vital for HCV replication. (2) An interferon sensitivity-determining region (ISDR, amino acids 237–276), associated with IFN resistance and lack of response to treatment in genotype 1a-infected patients. The 40-amino-acid ISDR and 26 amino acids downstream of the ISDR on NS5A constitute the IFN-induced, double-stranded RNA-activated protein kinase (PKR) binding domain. (3) A polyproline cluster, containing 2 classes of proline-rich motifs: Class I (consensus sequence KxxPxxP) and Class II (consensus PxxPxR), distinguished by the orientation adopted by the motif when bound to an Src homology 3 (SH3) domain of a number of cellular signaling proteins including Grb2, Amphiphysin II and Src-family tyrosine kinases. (4) A nuclear localization signal (NLS, aa 354 to 362) that does not direct NS5A to the nucleus by itself, but is nonetheless functional in directing nuclear translocation when placed at the amino terminus of a reporter gene. Bin-Amphiphysin-Rvs (BAR) domain, bridging integrator protein (Bin1) 1-binding site, and methyl-CpG binding domain (MBD) are shown in the diagram. Gastroenterology 2006 130, 995-999DOI: (10.1053/j.gastro.2006.01.072) Copyright © 2006 American Gastroenterological Association Terms and Conditions